Skip to content
Screener

Prime Medicine PRME Asset turnover

Asset turnover at other companies

Eli Lilly logo
Eli LillyLLY
0.7×0.0×
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
0.5×0.0×
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
0.1×0.0×
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
0.0×
Beam Therapeutics logo
Beam TherapeuticsBEAM
0.1×+0.1×
Regenxbio logo
RegenxbioRGNX
0.4×+0.1×

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$43.3M+18.9%
Net income-$42.1M+19.9%
EPS (diluted)-$0.24+41.5%

Balance sheet

See full
Cash & equivalents$61.1M-9.4%
Total debt$112.5M-6.1%
Total equity$39.8M-34.6%
Total assets$249.0M-10.7%

Cash flow

See full
Operating cash flow-$41.0M+0.9%
CapEx$46.0K-97.1%
Free cash flow-$41.1M+4.4%

Valuation

See full
Market cap$558.64M-8.7%
Enterprise value$609.98M-8.2%

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-373.3%-1,281pp
Debt / equity2.8×+0.9×
Current ratio3.1×-0.5×

Where this comes from

Calculated from Prime Medicine’s reported figures.

Based on trailing twelve months.

The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:03 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053883

FAQ

What is Prime Medicine's asset turnover?
Prime Medicine (PRME) reported asset turnover of 0× in Q4 2025.
How has Prime Medicine's asset turnover changed year-over-year?
Prime Medicine's asset turnover increased by 19.8% year-over-year, from 0× to 0×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.

Ask your AI about Prime Medicine's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude